You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思健康(02138.HK)盈警:預計年度淨虧損1.7億港元-1.9億港元
格隆匯 06-16 12:07

格隆匯6月16日丨醫思健康(02138.HK)公佈,截至2025年3月31日止年度,息稅折舊及攤銷前之盈利(即扣除利息、稅項、折舊及攤銷前之盈利)預期約爲3億港元至3.10億港元(2024財年:3.88億港元)。

經計及所有一次性及非經常性減值項目後,集團預期錄得公司權益持有人應佔虧損約1.70億港元至1.90億港元(2024財年:虧損1890萬港元),主要原因如下:

(i)集團服務點之商譽、合營企業、聯營公司貸款及物業、廠房及設備之非現金減值,預期約爲2.00億港元至2.10億港元;

(ii)投資物業、其他應收款項及財務資產的若幹非現金公平值虧損,預期約爲1.10億港元至1.20億港元;及

(iii)策略性出售若幹醫療資產的出售附屬公司收益約2.68億港元。

就2025財年的收入而言,預期集團於2025財年的收入約爲41.00億港元,而2024財年的收入則爲42.11億港元。

減值虧損是由於2025財年消費意欲整體疲弱的情況下,對所收購資產產生的未來現金流預期作出調整所致。上述減值爲一次性非現金開支,並不會對集團的整體營運現金流造成任何影響。董事會認爲,由於集團的現金狀況預期約爲10億港元,故本集團的整體資產負債表仍然穩健。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account